- Home
- BWA vs CORT Comparison
BWA vs CORT Comparison
Compare BWA & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWA
- CORT
- Stock Information
- Founded
- BWA 1987
- CORT 1998
- Country
- BWA United States
- CORT United States
- Employees
- BWA N/A
- CORT N/A
- Industry
- BWA Auto Parts:O.E.M.
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- BWA Consumer Discretionary
- CORT Health Care
- Exchange
- BWA Nasdaq
- CORT Nasdaq
- Market Cap
- BWA 6.6B
- CORT 7.1B
- IPO Year
- BWA 1993
- CORT N/A
- Fundamental
- Price
- BWA $29.49
- CORT $63.54
- Analyst Decision
- BWA Buy
- CORT Strong Buy
- Analyst Count
- BWA 15
- CORT 4
- Target Price
- BWA $40.46
- CORT $97.00
- AVG Volume (30 Days)
- BWA 2.7M
- CORT 929.7K
- Earning Date
- BWA 02-06-2025
- CORT 02-26-2025
- Dividend Yield
- BWA 1.49%
- CORT N/A
- EPS Growth
- BWA N/A
- CORT 57.97
- EPS
- BWA 1.50
- CORT 1.26
- Revenue
- BWA $14,086,000,000.00
- CORT $628,555,000.00
- Revenue This Year
- BWA $3.34
- CORT $46.47
- Revenue Next Year
- BWA $5.27
- CORT $21.49
- P/E Ratio
- BWA $18.09
- CORT $50.40
- Revenue Growth
- BWA N/A
- CORT 39.67
- 52 Week Low
- BWA $28.65
- CORT $20.84
- 52 Week High
- BWA $38.23
- CORT $75.00
- Technical
- Relative Strength Index (RSI)
- BWA 39.26
- CORT 46.90
- Support Level
- BWA $28.65
- CORT $71.50
- Resistance Level
- BWA $30.49
- CORT $75.00
- Average True Range (ATR)
- BWA 0.99
- CORT 3.33
- MACD
- BWA -0.02
- CORT -0.74
- Stochastic Oscillator
- BWA 19.40
- CORT 3.00
About BWA BorgWarner Inc.
BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2023, 25% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.